Eli Lilly Surges After 2017 Guidance Beats Street Forecast

Eli Lilly shares are up after the drugmaker offered 2017 earnings guidance above Wall Street's forecast.
Author:
Publish date:

Eli Lilly (LLY) - Get Report shares are up over 4% after the drugmaker offered 2017 earnings guidance above Wall Street's forecast. Lilly said it expects revenue for 2017 to fall somewhere between $21.8 billion and $22.3 billion compared with the consensus estimate of roughly $21.7 billion. The company guided earnings per share above the consensus, expecting somewhere between $4.05 and $4.15 a share, compared with analysts' expectations of $3.96.